Ad
related to: novartis ag (nvs)- Contact Us
Contact a PYLARIFY sales
representative to stay updated.
- Resources for PYLARIFY
Discover downloadable guides for
health care professionals.
- PYLARIFY Imaging Sites
Find or register a PYLARIFY
imaging site.
- PYLARIFY Updates
Be among the first to receive new
imaging locations & news updates.
- Contact Us
Search results
Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 month agoNovartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of the...
Investors Heavily Search Novartis AG (NVS): Here is What You Need to Know
Zacks via Yahoo Finance· 2 months agoZacks.com users have recently been watching Novartis (NVS) quite a bit. Thus, it is worth knowing...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo Finance· 1 month agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Novartis' (NVS) Shareholders Approve Sandoz Separation
Zacks via Yahoo Finance· 8 months agoNovartis AG NVS announced that its shareholders agreed to the proposed 100% spin-off of its generic...
Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?
Zacks via Yahoo Finance· 1 year agoHave you been paying attention to shares of Novartis (NVS)? Shares have been on the move with the...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 1 month agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug
Zacks via Yahoo Finance· 4 months agoNovartis NVS announced that it will acquire Germany-based global biopharmaceutical company MorphoSys...
Novartis (NVS) Announces Positive Data on Oncology Drug
Zacks via Yahoo Finance· 2 years agoNovartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo Finance· 1 month agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...
Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval
Zacks via Yahoo Finance· 1 year agoNovartis NVS announced that its cardiovascular drug Entresto (sacubitril/valsartan) has received a...
